The reduced levels of these two neurotransmitter metabolites, combined with other potential biomarkers, might be used to predict disease severity and movement disability in MS, even though the mechanisms through which these monoamine metabolites reversely regulate the progression of MS and the activities of neurotransmitters remain unclear
J Neurosci Res (2012) 90(10):1892902
The A53T transgenic mouse model effectively reflects the pathological manifestations of -syn, demonstrating significant neurodegeneration, deterioration of motor function, and non-motor symptoms (Taguchi et al., 2020)
Detection of glutathione in whole blood after stabilization with N -ethylmaleimide
Epithalon has been discussed in published scientific literature involving peptide biology, telomere biology, cellular aging research models, gene expression analysis, molecular signaling pathways, and controlled laboratory investigations